Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 2
1980 2
1981 3
1982 4
1983 4
1984 1
1985 1
1986 1
1987 3
1988 4
1989 1
1990 3
1991 1
1992 1
2003 1
2004 1
2005 1
2009 1
2010 2
2013 4
2014 1
2015 4
2016 3
2018 2
2019 3
2020 1
2021 2
2022 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.
Sulfonylureas and platelet function.
Klaff LJ, Kernoff L, Vinik AI, Jackson WP, Jacobs P. Klaff LJ, et al. Am J Med. 1981 Mar;70(3):627-30. doi: 10.1016/0002-9343(81)90585-4. Am J Med. 1981. PMID: 6782875 Review.
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. Pettus J, et al. Among authors: klaff lj. Nat Med. 2022 Oct;28(10):2092-2099. doi: 10.1038/s41591-022-02011-x. Epub 2022 Oct 3. Nat Med. 2022. PMID: 36192552 Free PMC article. Clinical Trial.
Fingerstick Precision and Total Error of a Point-of-Care HbA1c Test.
Arnold WD, Kupfer K, Hvidsten Swensen M, Fortner KS, Bays HE, Davis M, Klaff LJ, San George RC. Arnold WD, et al. Among authors: klaff lj. J Diabetes Sci Technol. 2020 Sep;14(5):890-895. doi: 10.1177/1932296819831273. Epub 2019 Mar 6. J Diabetes Sci Technol. 2020. PMID: 30841743 Free PMC article.
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. Pettus J, et al. Among authors: klaff lj. Nat Med. 2023 Nov;29(11):2959. doi: 10.1038/s41591-023-02301-y. Nat Med. 2023. PMID: 36932248 No abstract available.
61 results